Ikena Oncology, Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Ikena Oncology, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • Ikena Oncology, Inc. Return On Equity for the quarter ending September 30, 2024 was -39.6 %, a 6.34% increase year-over-year.
  • Ikena Oncology, Inc. annual Return On Equity for 2023 was -44.2 %, a 8.17% decline from 2022.
  • Ikena Oncology, Inc. annual Return On Equity for 2022 was -40.9 %, a 156% decline from 2021.
  • Ikena Oncology, Inc. annual Return On Equity for 2021 was -16 %, a 129% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -39.6 +2.68 +6.34% Jul 1, 2024 Sep 30, 2024
Q2 2024 -42.8 -0.79 -1.88% Apr 1, 2024 Jun 30, 2024
Q1 2024 -44 -0.99 -2.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -44.2 -3.34 -8.17% Oct 1, 2023 Dec 31, 2023
Q3 2023 -42.3 -14 -49.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -42 -16.8 -66.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -43 -22.9 -114% Jan 1, 2023 Mar 31, 2023
Q4 2022 -40.9 -24.9 -156% Oct 1, 2022 Dec 31, 2022
Q3 2022 -28.3 +17.9 +38.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -25.2 +57.5 +69.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -20.1 -785 -103% Jan 1, 2022 Mar 31, 2022
Q4 2021 -16 -71.2 -129% Oct 1, 2021 Dec 31, 2021
Q3 2021 -46.1 Jul 1, 2021 Sep 30, 2021
Q2 2021 -82.7 Apr 1, 2021 Jun 30, 2021
Q1 2021 765 Jan 1, 2021 Mar 31, 2021
Q4 2020 55.3 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.